1. P006 Host-genetics, dysbiosis, and clinical history explains fecal metabolic alterations in patients with Inflammatory Bowel Disease. (27th May 2021) Authors: Vich Vila, A; Hu, S; Andreu-Sánchez, S; Collij, V; Jansen, D; Ruigrok, R; Abu-Ali, G; Parkinson, J; Al Garawi, A; Schneider, J; Kurilshikov, A; Björk, J; Gacesa, R; Fu, J; Zhernakova, A; Weersma, R K Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P013 A single cell approach reveals immune cell dynamics in Inflammatory Bowel Disease (IBD) and highlights association of CD8 intraepithelial lymphocytes (IELs) with response to vedolizumab treatment. (21st January 2022) Authors: Paraskevopoulou, M; Mayer, L; Krueger, A; Pattekar, A; Ramos, A; Fulton, M; Wai Lau, C; Chau, L; Ren, Y; Tondon, R; Al Garawi, A; Bittinger, K; Fogt, F; Yajnik, V; Lee, H; Lewis, J; Wu, G; Bewtra, M; Tomov, V; Juarez, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗